Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hitoshi Hashimoto

Showing results (201-210 of 247) with videos related to

Pageof 25
Sort By:
JCI Insight|March 4, 2020
Direct visualization of an antidepressant analog using surface-enhanced Raman scattering in the brainMasato Tanuma, Atsushi Kasai, Kazuki Bando, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 3, 2006
Pituitary adenylate cyclase-activating polypeptide (PACAP) decreases ischemic neuronal cell death in association with IL-6Hirokazu Ohtaki, Tomoya Nakamachi, Kenji Dohi, et al.
Neuroscience Letters|November 26, 2009
Mice deficient in pituitary adenylate cyclase activating polypeptide display increased sensitivity to renal oxidative stress in vitroGabriella Horvath, Laszlo Mark, Reka Brubel, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 23, 2014
Differential regulatory role of pituitary adenylate cyclase-activating polypeptide in the serum-transfer arthritis modelBálint Botz, Kata Bölcskei, László Kereskai, et al.
Neurobiology of Disease|October 29, 2011
Pituitary adenylate cyclase-activating polypeptide plays a key role in nitroglycerol-induced trigeminovascular activation in miceAdrienn Markovics, Viktoria Kormos, Balazs Gaszner, et al.
The Journal of Investigative Dermatology|April 24, 2015
Pituitary Adenylate Cyclase-Activating Polypeptide Is Upregulated in Murine Skin Inflammation and Mediates Transient Receptor Potential Vanilloid-1-Induced Neurogenic EdemaZsuzsanna Helyes, Jozsef Kun, Nora Dobrosi, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 20, 2019
Pituitary Adenylate Cyclase-Activating Polypeptide Modulates Dendritic Spine Maturation and Morphogenesis via MicroRNA-132 UpregulationAtsuko Hayata-Takano, Toshihiko Kamo, Harui Kijima, et al.
Pharmacological Reports : PR|April 9, 2021
The pivotal role of pituitary adenylate cyclase-activating polypeptide for lactate production and secretion in astrocytes during fear memoryYuki Kambe, Yu Yamauchi, Trung Thanh Nguyen, et al.
Molecular Brain|March 29, 2022
Molecular brain (micro report) oxytocin ameliorates impaired social behavior in a mouse model of 3q29 deletion syndromeTomoya Takemoto, Masayuki Baba, Kazumasa Yokoyama, et al.
Behavioural Pharmacology|December 28, 2012
The selective metabotropic glutamate 2/3 receptor agonist MGS0028 reverses psychomotor abnormalities and recognition memory deficits in mice lacking the pituitary adenylate cyclase-activating polypeptideYukio Ago, Naoki Hiramatsu, Toshihiro Ishihama, et al.
Pageof 25

Showing results (201-210 of 247) with videos related to

Sort By:
Pageof 25
JCI Insight|March 4, 2020
Direct visualization of an antidepressant analog using surface-enhanced Raman scattering in the brainMasato Tanuma, Atsushi Kasai, Kazuki Bando, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 3, 2006
Pituitary adenylate cyclase-activating polypeptide (PACAP) decreases ischemic neuronal cell death in association with IL-6Hirokazu Ohtaki, Tomoya Nakamachi, Kenji Dohi, et al.
Neuroscience Letters|November 26, 2009
Mice deficient in pituitary adenylate cyclase activating polypeptide display increased sensitivity to renal oxidative stress in vitroGabriella Horvath, Laszlo Mark, Reka Brubel, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 23, 2014
Differential regulatory role of pituitary adenylate cyclase-activating polypeptide in the serum-transfer arthritis modelBálint Botz, Kata Bölcskei, László Kereskai, et al.
Neurobiology of Disease|October 29, 2011
Pituitary adenylate cyclase-activating polypeptide plays a key role in nitroglycerol-induced trigeminovascular activation in miceAdrienn Markovics, Viktoria Kormos, Balazs Gaszner, et al.
The Journal of Investigative Dermatology|April 24, 2015
Pituitary Adenylate Cyclase-Activating Polypeptide Is Upregulated in Murine Skin Inflammation and Mediates Transient Receptor Potential Vanilloid-1-Induced Neurogenic EdemaZsuzsanna Helyes, Jozsef Kun, Nora Dobrosi, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 20, 2019
Pituitary Adenylate Cyclase-Activating Polypeptide Modulates Dendritic Spine Maturation and Morphogenesis via MicroRNA-132 UpregulationAtsuko Hayata-Takano, Toshihiko Kamo, Harui Kijima, et al.
Pharmacological Reports : PR|April 9, 2021
The pivotal role of pituitary adenylate cyclase-activating polypeptide for lactate production and secretion in astrocytes during fear memoryYuki Kambe, Yu Yamauchi, Trung Thanh Nguyen, et al.
Molecular Brain|March 29, 2022
Molecular brain (micro report) oxytocin ameliorates impaired social behavior in a mouse model of 3q29 deletion syndromeTomoya Takemoto, Masayuki Baba, Kazumasa Yokoyama, et al.
Behavioural Pharmacology|December 28, 2012
The selective metabotropic glutamate 2/3 receptor agonist MGS0028 reverses psychomotor abnormalities and recognition memory deficits in mice lacking the pituitary adenylate cyclase-activating polypeptideYukio Ago, Naoki Hiramatsu, Toshihiro Ishihama, et al.
Pageof 25